Glucose-Dependent Insulinotropic Polypeptide Plasma Level Influences the Effect of n-3 PUFA Supplementation
Authors:
- Joanna GoralskaJGJoanna Goralska
- Urszula RaznyURUrszula Razny
- Philip C. CalderPCPhilip C. Calder
- Anna GrucaAGAnna Gruca
- Caroline E. ChildsCCCaroline E. Childs
- Piotr ZabielskiPZPiotr Zabielski
- Aldona Dembinska-KiecADAldona Dembinska-Kiec
- Maciej BanachMaciej Banach
- Bogdan SolnicaBSBogdan Solnica
- Malgorzata Malczewska-MalecMMMalgorzata Malczewska-Malec
Open Access
- 16 August 2022
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 12 (8) , 1984
Abstract
Elevated glucose-dependent insulinotropic peptide (GIP) levels in obesity may predict the metabolic benefits of n-3 PUFA supplementation. This placebo-controlled trial aimed to analyze fasting and postprandial GIP response to 3-month n-3 PUFA supplementation (1.8 g/d; DHA:EPA, 5:1) along with caloric restriction (1200–1500 kcal/d) in obese subjects. Compliance was confirmed by the incorporation of DHA and EPA into red blood cells (RBCs). Blood analyses of glucose, insulin, non-esterified fatty acids (NEFAs), GIP and triglycerides were performed at fasting, and during an oral glucose tolerance test and a high fat mixed-meal tolerance test. Fatty acid composition of RBC was assessed by gas chromatography and total plasma fatty acid content and composition was measured by gas–liquid chromatography. The DHA and EPA content in RBCs significantly increased due to n-3 PUFA supplementation vs. placebo (77% vs. −3%, respectively). N-3 PUFA supplementation improved glucose tolerance and decreased circulating NEFA levels (0.750 vs. 0.615 mmol/L), as well as decreasing plasma saturated (1390 vs. 1001 µg/mL) and monounsaturated (1135 vs. 790 µg/mL) fatty acids in patients with relatively high GIP levels. The effects of n-3 PUFAs were associated with the normalization of fasting (47 vs. 36 pg/mL) and postprandial GIP levels. Obese patients with elevated endogenous GIP could be a target group for n-3 PUFA supplementation in order to achieve effects that obese patients without GIP disturbances can achieve with only caloric restriction.Keywords
Funding Information
- European Commission (244995, DEC-2011/02/A/NZ2/00022, K/ZDS/007157, N41/DBS/000811)
- THE NATIONAL SCIENCE CENTRE (PL) (244995, DEC-2011/02/A/NZ2/00022, K/ZDS/007157, N41/DBS/000811)
- the MINISTRY OF SCIENCE AND HIGHER EDUCATION (PL) (244995, DEC-2011/02/A/NZ2/00022, K/ZDS/007157, N41/DBS/000811)
This publication has 38 references indexed in Scilit:
- Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trialsJournal of Human Nutrition and Dietetics, 2017
- Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive responseAmerican Journal of Physiology-Endocrinology and Metabolism, 2017
- Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator productionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2016
- ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart DiseaseJAMA Internal Medicine, 2016
- Effect of caloric restriction with or without n-3 polyunsaturated fatty acids on insulin sensitivity in obese subjects: A randomized placebo controlled trialBBA Clinical, 2015
- Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysisClinical Therapeutics, 2015
- High saturated fatty acid intake induces insulin secretion by elevating gastric inhibitory polypeptide levels in healthy individualsNutrition Research, 2014
- High-Throughput Analysis of Total Plasma Fatty Acid Composition with Direct In Situ TransesterificationPLOS ONE, 2010
- The omega-3 index as a risk factor for coronary heart diseaseThe American Journal of Clinical Nutrition, 2008
- Effect of a Supplemented Diet with Canned Sardine on the Lipid Fraction of Human Plasma and ErythrocytesJournal of Aquatic Food Product Technology, 2002